Mark Stewart

32PUBLICATIONS
192CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 28, 2026
A cross-national review of novel oncology approvals in the United States and China (2020-2025).

|Jun 04, 2026
Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative.

|Apr 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-up.

Betsy Foss-Campbell, Nancy Myers, Rakesh Awasthi

|Dec 11, 2025
Digital Biomarkers of Cytokine Release Syndrome: Scoping Review and Ontology Development of the Role and Relevance of Digital Measures Using a Mixed Methods Approach.

Christopher J Medberry, Charlotte Zoe Angel, Ashita S Batavia

|Dec 02, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recovery.

Mark D Stewart, Christopher R Cabanski, Jeff D Allen

|Sep 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy.

Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura

Pageof 6

Frequent Collaborators

10 joint publications

Hillary Stires

9 joint publications

Brittany McKelvey

9 joint publications

Jeff D Allen

5 joint publications

Diana Merino Vega